The Remdesivir Global Market Report 2021-31 by The Business Research Company describes and explains the global remdesivir market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
The Remdesivir
Global Market Report 2022 covers remdesivir market drivers, remdesivir market
trends, remdesivir market segments, remdesivir market growth rate, remdesivir market
major players, and remdesivir market size.
View Complete Report:
https://www.thebusinessresearchcompany.com/report/remdesivir-global-market-report
The remdesivir
market report provides in-depth analysis of the impact of COVID-19 on the global
remdesivir industry along with revised market numbers due to the effects of the
coronavirus and the expected remdesivir market growth numbers for 2022-2031.
The global
remdesivir market size is expected to grow from $2.87 billion in 2021 to $3.77
billion in 2022 at a compound annual growth rate (CAGR) of 31.2%. The growth in
the market is mainly due to the companies resuming their operations and
adapting to the new normal while recovering from the COVID-19 impact, which had
earlier led to restrictive containment measures involving social distancing,
remote working, and the closure of commercial activities that resulted in
operational challenges. The remdesivir market share is expected to reach $11.17
billion in 2026 at a CAGR of 31.2%.
Request Report Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp
Remdesivir Global
Market Report 2022 is the most comprehensive report available on this market
and will help gain a truly global perspective as it covers 60 geographies. The
chapter on the impact of COVID-19 gives valuable insights on supply chain
disruptions, logistical challenges, and other economic implications of the
virus on the market. The chapter also covers markets which have been positively
affected by the pandemic.
TBRC’s report
covers the remdesivir market segments-
1) By Route of Administration: Oral, Intravenous
2) By Dosage Form:
Tablets, Frozen Solution, Lypholized Solution
3) By
Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online,
Others
About The Business Research Company:
The Business
Research Company is a market intelligence firm that excels in company, market,
and consumer research. Located globally it has specialist consultants in a wide
range of industries including manufacturing, healthcare, financial services,
chemicals, and technology. It has offices in the UK, the US and India and
a network of trained researchers in 20+ countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Find us on
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
Blog: http://blog.tbrc.info/
No comments:
Post a Comment